Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-070830·Lilly Ventures Fund I LLC
Schedule 13D ownership disclosure
Protagonist Therapeutics Inc
Security class unavailable · CUSIP: 74366E102
Event date: 2020-05-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-070830
- Form type
- SC 13D/A
- Filer
- Lilly Ventures Fund I LLC
- CIK
- CIK 1575852
- Filed
- Jun 08, 2020
- Reporting period
- May 11, 2020
- Description
- Schedule 13D beneficial ownership